Relationship Between Intestinal Microbiota and Colorectal Cancer

World Journal of Gastrointestinal Oncology

Volumn 7, Issue 10, 2015, Pages 233-240

  Cipe, Gokhan ^a   Idiz, Ufuk Oguz ^b   Firat, Deniz ^b   Bektasoglu, Huseyin ^b  

^a FATIH UNIVERSITY   (Turkey)

^b BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Cancer; Colorectal; Intestinal; Microbiota; Sporadic

Indexed keywords

EID: 84977157095     PISSN: None     EISSN: 19485204     Source Type: Journal    
DOI: 10.4251/wjgo.v7.i10.233     Document Type: Article

References (100)

1. 1 Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, Déchelotte P, Bonnet R, Pezet D, Darfeuille-Michaud A. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res 2014; 20: 859-867 [PMID: 24334760 DOI: 10.1158/1078-0432.CCR-13-1343]
2. 2 O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Ko CY. Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum 2004; 47: 2064-2069 [PMID: 15657655 DOI: 10.1007/s10350-004-0738-1]
3. 3 Gueimonde M, Ouwehand A, Huhtinen H, Salminen E, Salminen S. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 2007; 13: 3985-3989 [PMID: 17663515 DOI: 10.3748/wjg.v13.i29.3985]
4. 4 Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31: 107-133 [PMID: 334036 DOI: 10.1146/annurev.mi.31.100177.000543]
5. 5 Salminen S, Isolauri E. Intestinal colonization, microbiota and probiotics. J Pediatr 2006; 149: 115-120 [DOI: 10.1016/j.jpeds.2006.06.062]
6. 6 Watson AJ, Collins PD. Colon cancer: a civilization disorder. Dig Dis 2011; 29: 222-228 [PMID: 21734388 DOI: 10.1159/000323926]
7. 7 Tappenden KA, Deutsch AS. The physiological relevance of the intestinal microbiota—contributions to human health. J Am Coll Nutr 2007; 26: 679S-683S [PMID: 18187433 DOI: 10.1080/07315724.2007.10719647]
8. 8 Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920 [PMID: 15790844 DOI: 10.1126/science.1104816]
9. 9 Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5: e9085 [PMID: 20140211 DOI: 10.1371/journal.pone.0009085]
10. 10 Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, Heuvelmans-Jacobs M, Akira S, Nicklin MJ, Ribeiro-Dias F, van den Berg WB. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008; 118: 205-216 [PMID: 18060042 DOI: 10.1172/JCI32639]
11. 11 Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023 [PMID: 17183309 DOI: 10.1038/4441022a]
12. 12 Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 2001; 166: 1487-1491 [PMID: 11547118 DOI: 10.1016/S0022-5347(05)65817-X]
13. 13 Tannock GW. Molecular analysis of the intestinal microflora in IBD. Mucosal Immunol 2008; 1 Suppl 1: S15-S18 [PMID: 19079221 DOI: 10.1038/mi.2008.54]
14. 14 Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3: 213-223 [PMID: 18407065 DOI: 10.1016/j.chom.2008.02.015]
15. 15 Hoffmann C, Hill DA, Minkah N, Kirn T, Troy A, Artis D, Bushman F. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect Immun 2009; 77: 4668-4678 [PMID: 19635824 DOI: 10.1128/IAI.00493-09]
16. 16 Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 2009; 136: 2015-2031 [PMID: 19462507 DOI: 10.1053/j.gastro.2009.01.072]
17. 17 Wlodarska M, Finlay BB. Host immune response to antibiotic perturbation of the microbiota. Mucosal Immunol 2010; 3: 100-103 [PMID: 20016473 DOI: 10.1038/mi.2009.135]
18. 18 Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2: 204 [PMID: 18030708 DOI: 10.1016/j.chom.2007.08.002]
19. 19 Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, Zhao G, Chen Y, Zhao L. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2010; 4: 232-241 [PMID: 19865183 DOI: 10.1038/ismej.2009.112]
20. 20 Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455: 1109-1113 [PMID: 18806780 DOI: 10.1038/nature07336]
21. 21 Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-484 [PMID: 19043404 DOI: 10.1038/nature07540]
22. 22 Schulz MD, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, Ziegler PK, Varga J, Reindl W, Pommerenke C, Salinas-Riester G, Böck A, Alpert C, Blaut M, Polson SC, Brandl L, Kirchner T, Greten FR, Polson SW, Arkan MC. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 2014; 514: 508-512 [PMID: 25174708 DOI: 10.1038/nature13398]
23. 23 Bingham S, Riboli E. Diet and cancer—the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004; 4: 206-215 [PMID: 14993902 DOI: 10.1038/nrc1298]
24. 24 Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, Soyletir G. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006; 12: 782-786 [PMID: 16842574 DOI: 10.1111/j.1469-0691.2006.01494.x]
25. 25 Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res 2008; 68: 9909-9917 [PMID: 19047172 DOI: 10.1158/0008-5472.CAN-08-1551]
26. 26 Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15: 1016-1022 [PMID: 19701202 DOI: 10.1038/nm.2015]
27. 27 Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 2010; 107: 11537-11542 [PMID: 20534522 DOI: 10.1073/pnas.1001261107]
28. 28 Ge Z, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, Fox JG. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 2007; 9: 2070-2080 [PMID: 17441986 DOI: 10.1111/j.1462-5822.2007.00939.x]
29. 29 Kim DH, Jin YH. Intestinal bacterial beta-glucuronidase activity of patients with colon cancer. Arch Pharm Res 2001; 24: 564-567 [PMID: 11794536 DOI: 10.1007/BF02975166]
30. 30 Jubelin G, Chavez CV, Taieb F, Banfield MJ, Samba-Louaka A, Nobe R, Nougayrède JP, Zumbihl R, Givaudan A, Escoubas JM, Oswald E. Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One 2009; 4: e4855 [PMID: 19308257 DOI: 10.1371/journal.pone.0004855]
31. 31 Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA 2005; 102: 16339-16344 [PMID: 16258069 DOI: 10.1073/pnas.0502598102]
32. 32 Knasmüller S, Steinkellner H, Hirschl AM, Rabot S, Nobis EC, Kassie F. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat Res 2001; 480-481: 129-138 [PMID: 11506806 DOI: 10.1016/S0027-5107(01)00176-2]
33. 33 Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 2007; 67: 445-449 [PMID: 17234750 DOI: 10.1158/0008-5472.CAN-06-3861]
34. 34 Fiala ES. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer 1977; 40: 2436-2445 [PMID: 200341 DOI: 10.1002/1097-0142(197711)40]
35. 35 Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998; 19: 281-285 [PMID: 9498277 DOI: 10.1093/carcin/19.2.281]
36. 36 Laqueur GL, McDaniel EG, Matsumoto H. Tumor induction in germfree rats with methylazoxymethanol (MAM) and synthetic MAM acetate. J Natl Cancer Inst 1967; 39: 355-371 [PMID: 18623950]
37. 37 Rowland IR. The role of the gastrointestinal microbiota in colorectal cancer. Curr Pharm Des 2009; 15: 1524-1527 [PMID:19442169 DOI: 10.2174/138161209788168191]
38. 38 Neufert C, Becker C, Neurath MF. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammationdriven tumor progression. Nat Protoc 2007; 2: 1998-2004 [PMID: 17703211 DOI: 10.1038/nprot.2007.279]
39. 39 Takada H, Hirooka T, Hiramatsu Y, Yamamoto M. Effect of beta-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res 1982; 42: 331-334 [PMID: 7053860]
40. 40 Geier MS, Butler RN, Howarth GS. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? Cancer Biol Ther 2006; 5: 1265-1269 [PMID: 16969130 DOI: 10.4161/cbt.5.10.3296]
41. 41 Goldin BR, Gorbach SL. Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides. J Natl Cancer Inst 1984; 73: 689-695 [PMID: 6433097]
42. 42 Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst 1980; 64: 255-261 [PMID: 6766508]
43. 43 Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC, Platz EA, Pardoll DM, Sears CL. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 2015; 60: 208-215 [PMID: 25305284 DOI: 10.1093/cid/ciu787]
44. 44 Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, Dean PJ, Kimmey M, Perera DR, Rabinovitch PS. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992; 103: 1611-1620 [PMID: 1426881]
45. 45 Porschen R, Robin U, Schumacher A, Schauseil S, Borchard F, Hengels KJ, Strohmeyer G. DNA aneuploidy in Crohn’s disease and ulcerative colitis: results of a comparative flow cytometric study. Gut 1992; 33: 663-667 [PMID: 1612484 DOI: 10.1136/gut.33.5.663]
46. 46 Sjöqvist U, Befrits R, Söderlund S, Ost A, Karlén P, Tribukait B, Rubio C, Rutgeerts P, Geboes K, Löfberg R. Colorectal cancer in colonic Crohn’s disease—high frequency of DNA-aneuploidy. Anticancer Res 2005; 25: 4393-4397 [PMID: 16334114]
47. 47 Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 2002; 160: 2253-2257 [PMID: 12057927 DOI: 10.1016/S0002-9440(10)61172-8]
48. 48 Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005; 128: 891-906 [PMID: 15825073 DOI: 10.1053/j.gastro.2005.02.009]
49. 49 Wang X, Huycke MM. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 2007; 132: 551-561 [PMID: 17258726 DOI: 10.1053/j.gastro.2006.11.040]
50. 50 Segain JP, Raingeard de la Blétière D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottière HM, Galmiche JP. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn’s disease. Gut 2000; 47: 397-403 [PMID: 10940278 DOI: 10.1136/gut.47.3.397]
51. 51 Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282-1286 [PMID: 19865172 DOI: 10.1038/nature08530]
52. 52 Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994; 35: S35-S38 [PMID: 8125387 DOI: 10.1136/gut.35.1_Suppl.S35]
53. 53 Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5: 769-784 [PMID: 16955068 DOI: 10.1038/nrd2133]
54. 54 Heerdt BG, Houston MA, Augenlicht LH. Short-chain fatty acidinitiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Differ 1997; 8: 523-532 [PMID: 9149903]
55. 55 Bonnotte B, Favre N, Reveneau S, Micheau O, Droin N, Garrido C, Fontana A, Chauffert B, Solary E, Martin F. Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate. Cell Death Differ 1998; 5: 480-487 [PMID: 10200499 DOI: 10.1038/sj.cdd.4400371]
56. 56 Hague A, Elder DJ, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 1995; 60: 400-406 [PMID: 7829251 DOI: 10.1002/ijc.2910600322]
57. 57 Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 2003; 52: 94-100 [PMID: 12477768 DOI: 10.1136/gut.52.1.94]
58. 58 Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, Mellinger JD, Smith SB, Digby GJ, Lambert NA, Prasad PD, Ganapathy V. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 2009; 69: 2826-2832 [PMID: 19276343 DOI: 10.1158/0008-5472.CAN-08-4466]
59. 59 Park JY, Helm JF, Zheng W, Ly QP, Hodul PJ, Centeno BA, Malafa MP. Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer. Pancreas 2008; 36: e32-e39 [PMID: 18437076 DOI: 10.1097/MPA.0b013e3181630ffe]
60. 60 Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K, Margeson D, Davuluri R, Wen J, Witte T, Yu L, Liu C, Bloomfield CD, Marcucci G, Plass C, Caligiuri MA. DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood 2008; 112: 2013-2016 [PMID: 18566324 DOI: 10.1182/blood-2008-01-128595]
61. 61 Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 2012; 48: 612-626 [PMID: 23063526 DOI: 10.1016/j.molcel.2012.08.033]
62. 62 Belcheva A, Irrazabal T, Martin A. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health? Bioessays 2015; 37: 403-412 [PMID: 25601287 DOI: 10.1002/bies.201400204]
63. 63 Yang T, Owen JL, Lightfoot YL, Kladde MP, Mohamadzadeh M. Microbiota impact on the epigenetic regulation of colorectal cancer. Trends Mol Med 2013; 19: 714-725 [PMID: 24051204 DOI: 10.1016/j.molmed.2013.08.005]
64. 64 Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, Fox JG. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003; 162: 691-702 [PMID: 12547727 DOI: 10.1016/S0002-9440(10)63863-1]
65. 65 Nagamine CM, Rogers AB, Fox JG, Schauer DB. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice. Int J Cancer 2008; 122: 832-838 [PMID: 17957786 DOI: 10.1002/ijc.23175]
66. 66 Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 2006; 66: 828-838 [PMID: 16424015 DOI: 10.1158/0008-5472. CAN-05-2448]
67. 67 Nagamine CM, Sohn JJ, Rickman BH, Rogers AB, Fox JG, Schauer DB. Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(-/-) Apc(Min/+) mouse. Infect Immun 2008; 76: 2758-2766 [PMID: 18411292 DOI: 10.1128/IAI.01604-07]
68. 68 Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006; 66: 7395-7400 [PMID: 16885333 DOI: 10.1158/0008-5472.CAN-06-0558]
69. 69 Erdman SE, Rao VP, Poutahidis T, Ihrig MM, Ge Z, Feng Y, Tomczak M, Rogers AB, Horwitz BH, Fox JG. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 2003; 63: 6042-6050 [PMID: 14522933]
70. 70 Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL. Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/-mice results in colitis that progresses to dysplasia. Am J Pathol 2005; 166: 1793-1806 [PMID: 15920164 DOI: 10.1016/S0002-9440(10)62489-3]
71. 71 Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol 2002; 160: 739-751 [PMID: 11839595 DOI: 10.1016/S0002-9440(10)64894-8]
72. 72 Chichlowski M, Sharp JM, Vanderford DA, Myles MH, Hale LP. Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammationassociated neoplasia in IL10-deficient mice. Comp Med 2008; 58: 534-541 [PMID: 19149410]
73. 73 Hale LP, Perera D, Gottfried MR, Maggio-Price L, Srinivasan S, Marchuk D. Neonatal co-infection with helicobacter species markedly accelerates the development of inflammation-associated colonic neoplasia in IL-10(-/-) mice. Helicobacter 2007; 12: 598-604 [PMID: 18001399 DOI: 10.1111/j.1523-5378.2007.00552.x]
74. 74 Zarkin BA, Lillemoe KD, Cameron JL, Effron PN, Magnuson TH, Pitt HA. The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg 1990; 211: 786-791; discussion 791-792 [PMID: 2357141]
75. 75 Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004; 139: 760-765 [PMID: 15249410 DOI: 10.1001/archsurg.139.7.760]
76. 76 Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977; 297: 800-802 [PMID: 408687 DOI: 10.1056/NEJM197710132971503]
77. 77 Ruoff KL, Miller SI, Garner CV, Ferraro MJ, Calderwood SB. Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol 1989; 27: 305-308 [PMID: 2915024]
78. 78 Ellmerich S, Schöller M, Duranton B, Gossé F, Galluser M, Klein JP, Raul F. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 2000; 21: 753-756 [PMID: 10753212 DOI: 10.1093/carcin/21.4.753]
79. 79 Boleij A, Roelofs R, Schaeps RM, Schülin T, Glaser P, Swinkels DW, Kato I, Tjalsma H. Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients. Cancer 2010; 116: 4014-4022 [PMID: 20564125 DOI: 10.1002/cncr.25212]
80. 80 Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Metaanalysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125: 1636-1644 [PMID: 14724815 DOI: 10.1053/j.gastro.2003.08.033]
81. 81 Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6: e16393 [PMID: 21297998 DOI: 10.1371/journal.pone.0016393]
82. 82 Uronis JM, Mühlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitisassociated colorectal cancer susceptibility. PLoS One 2009; 4: e6026 [PMID: 19551144 DOI: 10.1371/journal.pone.0006026]
83. 83 Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology 2004; 127: 80-93 [PMID: 15236175 DOI: 10.1053/j.gastro.2004.03.054]
84. 84 Luperchio SA, Schauer DB. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 2001; 3: 333-340 [PMID: 11334751 DOI: 10.1016/S1286-4579(01)01387-9]
85. 85 Barthold SW, Jonas AM. Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res 1977; 37: 4352-4360 [PMID: 922726]
86. 86 Newman JV, Kosaka T, Sheppard BJ, Fox JG, Schauer DB. Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis 2001; 184: 227-230 [PMID: 11424022 DOI: 10.1086/321998]
87. 87 Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306 [PMID: 22009989 DOI: 10.1101/gr.126516.111]
88. 88 Gao Z, Guo B, Gao R, Zhu Q, Qin H. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol 2015; 6: 20 [PMID: 25699023 DOI: 10.3389/fmicb.2015.00020]
89. 89 Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, Moris F, Rodrigo L, Mira A, Collado MC. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 2015; 50: 167-179 [PMID: 24811328 DOI: 10.1007/s00535-014-0963-x]
90. 90 Zhu Q, Jin Z, Wu W, Gao R, Guo B, Gao Z, Yang Y, Qin H. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One 2014; 9: e90849 [PMID: 24603888 DOI: 10.1371/journal.pone.0090849]
91. 91 Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 2008; 23: 1298-1303 [PMID: 18624900 DOI: 10.1111/j.1440-1746.2008.05490.x]
92. 92 Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 2013; 8: e70803 [PMID: 23940645 DOI: 10.1371/journal.pone.0070803]
93. 93 Lightfoot YL, Yang T, Sahay B, Mohamadzadeh M. Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus. Gut Microbes 2013; 4: 84-88 [PMID: 23137966 DOI: 10.4161/gmic.22822]
94. 94 Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, Bere P, Sarraj B, Khan MW, Pakanati KC, Ansari MJ, O’Flaherty S, Barrett T, Klaenhammer TR. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci USA 2011; 108 Suppl 1: 4623-4630 [PMID: 21282652 DOI: 10.1073/pnas.1005066107]
95. 95 Licciardi PV, Wong SS, Tang ML, Karagiannis TC. Epigenome targeting by probiotic metabolites. Gut Pathog 2010; 2: 24 [PMID: 21172038 DOI: 10.1186/1757-4749-2-24]
96. 96 Jones SE, Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 2009; 9: 35 [PMID: 19210794 DOI: 10.1186/1471-2180-9-35]
97. 97 Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52: 988-997 [PMID: 12801956 DOI: 10.1136/gut.52.7.988]
98. 98 Qin H, Zhang Z, Hang X, Jiang Y. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol 2009; 9: 63 [PMID: 19331693 DOI: 10.1186/1471-2180-9-63]
99. 99 Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA 2010; 107: 454-459 [PMID: 20018654 DOI: 10.1073/pnas.0910307107]
100. 100 Liévin-Le Moal V, Amsellem R, Servin AL, Coconnier MH. Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells. Gut 2002; 50: 803-811 [PMID: 12010882 DOI: 10.1136/gut.50.6.803]